Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LillyDirect Foundayo vs PepHaūs

LillyDirect Foundayo
Graded #165

Lower grade

vs+15.5
PepHaūs
Graded #32

Higher grade

The verdict

PepHaūs takes it — 82.7/100 to 67.2/100.

PepHaūs grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Verified and nationwide, but priced in the upper-mid band ($152/$246).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePepHaūs +10
72
82
Dose & formulationPepHaūs +21
59
80
Clinical oversightPepHaūs +6
78
84
Labs & monitoringPepHaūs +30
52
82
FulfillmentPepHaūs +6
80
86
Contract termsPepHaūs +30
55
85
LillyDirect Foundayo · left barPepHaūs · right bar

The numbers

MetricLillyDirect FoundayoPepHaūs
WeighScore67.2/10082.7/100
GradeCB−
Scorecard rank#165#32
SemaglutideNot disclosed$152/mo
TirzepatideNot disclosed$246/mo
CoverageAll 50 statesAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
LillyDirect Foundayo

Graded #165 · C

Strengths

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Where it loses points

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow
PepHaūs

Graded #32 · B−

Strengths

  • LegitScript-verified, all 50 states
  • Both molecules
  • Transparent listed pricing

Where it loses points

  • Upper-mid pricing ($152/$246)
  • Injection-only
  • Monitoring detail limited

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard